Long-Term and Short-Term Effects of Hemodialysis on Liver Function Evaluated Using the Galactose Single-Point Test

Table 1

The demographic data and biochemistry parameters of the patients in the study ().


Variables	Values	Value of reference

Demographics
Age (years)	60.38 ± 11.86
Female (%)	28 (37.84)
Hepatitis B carrier (%)	6 (8.18)
Hepatitis C carrier (%)	4 (5.40)
Predialysis body weight (kg)	62.50 ± 9.89
Etiology of end-stage renal disease
Diabetes mellitus	14 (18.9%)
Polycystic kidney disease	2 (2.7%)
Preclampsia	1 (1.4%)
Cormobidity
Hypertension	16 (21.6%)
Coronary artery disease	16 (21.6%)
Malignancy	5 (6.75%)
Medication
ACEi/ARB	9 (12.1%)
Statin	2 (2.7%)
Phosphate binder	39 (52.7%)
Acetaminophen	11 (14.8%)
Phenytoin	2 (2.7%)
Rifampicin	1 (1.4%)
Biochemistry parameters
Glucose (mg/dL)	124.83 ± 68.45	90–105
AST (U/L)	22.19 ± 17.04	40
ALT (U/L)	18.47 ± 15.38	40
Alk-p (U/L)	78.07 ± 56.28	30–95
Albumin (g/dL)	4.05 ± 0.35	3.5–5.0
Uric acid (mg/dL)	7.24 ± 1.19	4.0–6.2

Variables	Values

Cr (mg/dL)
Predialysis	11.42 ± 2.02
Postdialysis	4.49 ± 3.32
BUN (mg/dL)
Predialysis	72.71 ± 21.51
Postdialysis	19.13 ± 8.88
Hematocrit (%)
Predialysis	28.60 ± 5.60
Post-dialysis	29.62 ± 6.26
Months of Dialysis (months)	60.77 ± 48.23
Pre-dialysis GSP (g/mL)	457.94 ± 297.83

Note: = valid cases, AST = Aspartate transaminase, ALT = alanine aminotransferase, Cr = serum creatinine, BUN = blood urea nitrogen, alk-p = alkaline phosphatase, GSP = galactose single point.

The Scientific World Journal

Long-Term and Short-Term Effects of Hemodialysis on Liver Function Evaluated Using the Galactose Single-Point Test

Table 1